It has been reported that Nrg4 can reach hepatocytes through the bloodstream, bind to ErbB4, and subsequently activate its downstream signaling pathway to regulate lipid metabolism in obese MASLD patients [13, 42, 43]. The gene discussed is ERBB4; the disease is metabolic dysfunction-associated steatotic liver disease.